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The syndrome of inappropriate antidiuretic hormone secretion has only been report-
ed in a few patients with large cell neuroendocrine carcinoma (LCNEC); however, it 
has never been reported in a patient with LCNEC of the lung, whose serum sodi-
um levels were normalized after surgical resection of the mass. A 63-year-old male 
presented with a two-day history of dizziness and recent memory loss. On admis-
sion, his serum sodium level was 113 mEq/L with a serum osmolality of 236 
mosm/kg, a urine osmolality of 441 mosm/kg, and a urine sodium level of 65 
mEq/L. His chest computed tomography revealed a 2.7×2.3 cm-sized mass in the 
left lower lobe. After surgical removal of the mass, his serum sodium concentra-
tions were normalized, and histopathology of the mass revealed LCNEC.
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INTRODUCTION
Since Schwartz, et al.1 first described the syndrome of inappropriate antidiuretic 
hormone secretion (SIADH) in two patients with lung cancer in 1957, there have 
been a number of reports of SIADH in patients with malignancies.2 To date, how-
ever, there were only a few reports of cases of SIADH in a patient with large cell 
neuroendocrine carcinoma (LCNEC). Furthermore there were no reports of a case 
of SIADH in a patient with LCNEC of the lung, whose serum sodium levels were 
normalized after surgical resection of the mass. 
CASE REPORT
A 63-year-old male was admitted to our hospital because of a two-day history of 
dizziness, general weakness, and recent memory loss. The patient had a ten-year 
history of diabetes mellitus and an eight-year history of hypertension. He also had 
a 60 pack-year history of smoking.
Upon admission, physical examinations revealed no evidence of volume deple-
tion, and neurologic examinations revealed no abnormalities except for slightly 
slurred speech. Laboratory studies showed microcytic hypochromic anemia, a blood 
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(3% NaCl: 20 gtt/min for 12 hours) with frequent monitor-
ing of serum sodium levels because of suspected hypona-
tremic symptoms at the emergency room. Subsequent se-
rum sodium concentrations thereafter were 113, 117, 119, 
and 121 mEq/L. After improvement in hyponatremic symp-
toms, his treatment was switched to isotonic saline infusion 
and furosemide (20 mg bid per os). The follow-up serum 
sodium level was 122 mEq/L and increased to 127 mEq/L 
at the time of a lung biopsy, which was performed through 
mediastinoscopy and revealed a neuroendocrine carcinoma. 
The patient underwent video-assisted thoracoscopic lobec-
tomy of the left lower lobe with mediastinal lymph node 
dissection. The mass was revealed to be a 3×2.2 cm-sized 
LCNEC with visceral pleural invasion (Fig. 2). In addition, 
an enlarged interlobar lymph node was observed and re-
moved. The final stage of LCNEC was T2N0M0 (IB). After 
surgical removal of the lung mass, his serum sodium con-
centrations were normalized (135 and 137 mEq/L) without 
any additional specific management. During the follow-up 
at an outpatient clinic, the patient received adjuvant chemo-
therapy with MAGE-A3 antigen-specific cancer immuno-
therapeutic, and hyponatremia did not recur.
DISCUSSION
SIADH is a common cause of hyponatremia in patients 
with malignancies.2 Even though small cell lung cancer 
(SCLC) is responsible for more than 60% of tumor-associ-
ated SIADHs,3 SIADH may also occur in patients with non-
SCLC as well as in patients with a variety of tumors.3 We 
herein report for the first time a case of SIADH in a patient 
with LCNEC of the lung, whose serum sodium levels were 
urea nitrogen of 9.3 mg/dL, and a serum creatinine of 0.88 
mg/dL. Urinalysis revealed trace proteinuria with no signifi-
cant casts. Serum sodium concentration was 113 mEq/L with 
a serum osmolality of 236 mosm/kg, a urine osmolality of 
441 mosm/kg, and a urine sodium concentration of 65 mEq/
L. His thyroid and adrenal functions were normal. The pa-
tient denied excessive water ingestion and the usage of di-
uretics or any other medications affecting serum sodium lev-
els. Based on the above information, he was diagnosed with 
SIADH.
No newly developed lesions in the central nervous sys-
tem were found on a brain magnetic resonance imaging 
with angiography. An approximately 2.5 cm-sized round 
mass lesion on the left perihilar area was noticed on a chest 
X-ray, and chest computed tomography revealed a 2.7×2.3 
cm-sized well-defined lobulated mass in the superior seg-
ment of the left lower lobe (Fig. 1).
The patient was initially treated with hypertonic saline 
Fig. 1. Chest computed tomography revealed a 2.7×2.3 cm-sized well-de-
fined lobulated mass in the superior segment of the left lower lobe, abut-
ting on the parietal pleura.
Fig. 2. Immunohistochemical staining showed diffusely strong staining for synaptophysin (A) and Ki-67 (B).
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completely normalized after surgical resection of the mass.
LCNEC is an uncommon tumor of the lung and belongs 
to the category of neuroendocrine tumors of the lung, along 
with typical carcinoid tumor, atypical carcinoid tumor, and 
SCLC.4 Since LCNEC has been regarded as a new type of 
lung cancer distinct from SCLC for only 20 years, the clini-
cal features and prognosis thereof have not been extensively 
explored.5 Previous studies have demonstrated that most pa-
tients with LCNEC are male and have a heavy smoking his-
tory.5 In addition, no significant differences in the clinical 
symptoms and signs between patients with LCNEC and 
those with other lung cancers have been reported.5 In con-
trast to SCLC, no paraneoplastic phenomenon was observed 
at the time of diagnosis in 87 patients with LCNEC.6 On the 
other hand, Johnson, et al.7 reported a patient with LCNEC 
that developed hyponatremia and described a response of 
serum sodium levels during chest radiotherapy and chemo-
therapy. However, there has been no report of a case of SI-
ADH in a patient with LCNEC of the lung, whose serum 
sodium levels were normalized after surgical resection of 
the mass. We surmise that this case may be the first report of 
SIADH in a patient with LCNEC, whose serum sodium lev-
els were resolved after surgical resection of the mass.
Previous studies also demonstrated that SIADH may antici-
pate the diagnosis of malignancy several months in advance.8 
In addition, SIADH is known to have a similar course to the 
underlying tumor.2 Therefore, serial measurements of serum 
sodium levels in these patients during follow-up may be use-
ful for monitoring the status of LCNEC.
